AutoImmune is a biopharmaceutical company engaged in the development of orally administered products that treat autoimmune and other cell-mediated inflammatory diseases. The company s products are based on a common biological mechanism known as oral tolerance, which provides tissue-specific immunosuppression to control disease without toxicity or significant side effects. The company has exclusively licensed certain of its intellectual property rights to BioMS Medical Corporation and Teva Pharmaceutical Industries, which are both engaged in the development and production of treatments for multiple sclerosis. AutoImmune is a publicly traded company. Its shares are listed on the OTC Bulletin Board under the symbol AIMM. AutoImmune is headquartered in Pasadena, Calif.
Partial Data by Infogroup (c) 2024. All rights reserved.
Partial Data by Foursquare.